Treatment With DAAs for HCV and Risk of HCC Treatment With DAAs for HCV and Risk of HCC

This study indicates that the risk of hepatocellular carcinoma remains high in HCV patients with advanced fibrosis, even after achieving viral eradication with DAAs.Liver International
Source: Medscape Pathology Headlines - Category: Pathology Tags: Gastroenterology Journal Article Source Type: news